Previously, three cognate LPA GPCRs (LP A1 /VZG-1/ EDG-2, LP A2 /EDG-4, and LP A3 /EDG-7) were identified in mammals. By contrast, an unrelated GPCR, PSP24, was reported to be a high affinity LPA receptor in Xenopus laevis oocytes, raising the possibility that Xenopus uses a very different form of LPA signaling. Toward addressing this issue, we report two novel Xenopus genes, xlp A1 -1 and xlp A1 -2, encoding LP A1 homologs (ϳ90% amino acid sequence identity with mammalian LP A1 ). Both xlp A1 -1 and xlp A1 -2 are expressed in oocytes and the nervous system. Overexpression of either gene in oocytes potentiated LPA-induced oscillatory chloride ion currents through a pertussis toxin-insensitive pathway. Injection of antisense oligonucleotides designed to inhibit xlp A1 -1 and xlp A1 -2 expression in oocytes eliminated their endogenous response to LPA. Furthermore, retrovirus-mediated heterologous expression of xlp A1 -1 or xlp A1 -2 in B103 rat neuroblastoma cells that are unresponsive to LPA conferred LPA-induced cell rounding and adenylyl cyclase inhibition. These results indicate that XLP A1 -1 and XLP A1 -2 are functional Xenopus LPA receptors and demonstrate the evolutionary conservation of LPA signaling over a range of vertebrate phylogeny.
; 1-acyl-2-sn-glycerol-3-phosphate) is a simple phospholipid that exerts hormone-and growth factor-like effects in many organisms and organ systems. LPA can alter cell fates by inducing proliferation and differentiation or by preventing apoptosis in many cell types (1) . In addition, LPA can induce cytoskeletal reorganization that leads to cell rounding and stress fiber formation (1) (2) (3) .
Biological responses to LPA are elicited by activation of its specific G protein-coupled receptors (GPCRs). Thus far, three genes (lp A1 , lp A2 , and lp A3 ) encoding high affinity LPA receptors, LP A1 /EDG-2, LP A2 /EDG-4, and LP A3 /EDG-7, have been identified in mammals (reviewed in Refs. 3 and 4) . Biological functions of these receptors have been characterized by overexpression and/or heterologous expression in mammalian cells (5) (6) (7) (8) (9) (10) (11) (12) (13) . All three LPA receptors can mediate adenylyl cyclase inhibition, increases in intracellular calcium, inositol phosphate production, and MAP kinase activation. LP A1 and LP A2 can also induce cell rounding via activation of the small GTPase, Rho. Pharmacological studies suggest that both LP A1 and LP A2 couple to at least three types of G proteins, G i/o , G 12/13 , and G q , whereas LP A3 couples with G i/o and G q but not with G 12/13 (13) . Genetic deletion of LP A1 in mice demonstrated that LP A1 is at least in part responsible for LPA signaling in vivo and is essential for normal development (14) .
A molecularly different LPA receptor was reported in studies on Xenopus oocytes (15) . Guo et al. (15) isolated a novel GPCR gene, PSP24, by polymerase chain reaction (PCR) using degenerate oligonucleotide primers against a platelet-activating factor receptor. Overexpression of PSP24 in oocytes potentiated maximal LPA-induced oscillatory chloride ion (Cl Ϫ ) currents, whereas injection of antisense oligonucleotide against PSP24 inhibited endogenous responses to LPA. Based on these observations, the authors concluded that PSP24 is a high affinity receptor for LPA. However, subsequent studies by others were inconsistent with this conclusion. Heterologous expression of PSP24 did not mediate LPA responses in yeast, whereas LP A1 did (7) . In addition, mammalian orthologs of PSP24 did not mediate responses to LPA in assays such as [ 35 S]GTP␥S binding, [ 3 H]LPA binding, MAP kinase activation, [ 3 H]thymidine incorporation, adenylyl cyclase inhibition, and increases in intracellular calcium (16, 17) .
Mouse, human, and Xenopus homologs of PSP24 share Ն55% amino acid sequence identity with one another (18) . These PSP24s have comparatively little amino acid sequence identity (Յ20%) with members of the mammalian LP A receptor family (4) . They instead show closest similarity to receptors for a bioactive peptide, cholecystokinin (4). The dissimilarity between mammalian and Xenopus LPA receptors was surprising based on the phylogenetic conservation of many other GPCRs * This work was supported by grants from the National Institute of Mental Health (to J. C.), the National Institute of Neuroscience, Japan (to H. K.), and the Uehara Memorial Foundation (to N. F. and I. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The for a single ligand. This disparity raises the question of whether Xenopus might use a fundamentally different LPA receptor system or might also express and use LPA receptors homologous to those found in mammals. Here, we report identification and characterization of two novel Xenopus GPCRs that show 89 -90% amino acid sequence identity with mammalian LP A1 .
EXPERIMENTAL PROCEDURES

Materials-[␣-
32 P]deoxy CTP was purchased from PerkinElmer Life Sciences. LPA (1-oleoyl-2-hydroxy-sn-glycero-3-phosphate) was purchased from Avanti Polar Lipids (Alabaster, AL). Pertussis toxin (PTX) was purchased from Calbiochem (La Jolla, CA). B103 rat neuroblastoma cells (19) were a gift from Dr. David Schubert (The Salk Institute, La Jolla, CA). RH7777 rat hepatoma cells were a gift from Dr. Hyam Leffert (University of California, San Diego, La Jolla, CA). Retrovirus expression vector (LZRS-EGFP) and Phoenix ecotropic retrovirus producer cell lines were gifts from Dr. Garry P. Nolan (Stanford University, Stanford, CA). Y-27632 was a gift from Welfide Pharmaceutical Industries (Saitama, Japan). Trizol and all cell culture reagents were purchased from Life Technologies, Inc. Anti-GFP antibody was obtained from CLONTECH (Palo Alto, CA). Forskolin, 3-isobutyl-1-methylxanthine, anti-FLAG M2 monoclonal antibody, and other reagents were purchased from Sigma, unless otherwise noted.
Amplification of Xenopus cDNAs by Reverse Transcription-PCR-mRNA was prepared from Xenopus oocytes using the Oligotex direct mRNA kit (Qiagen, Valentia, CA) as described by Ferby et al. (20) . First strand cDNA was synthesized from 500 ng of mRNA using oligo(dT) primers and the SUPERSCRIPT first-strand synthesis system (Life Technologies, Inc.). This cDNA was used as a template for PCR with degenerate primers designed toward sequences in transmembrane domains (TMD) II and VII conserved among members of the GPCR family (21) . The nucleotide sequence for the TMD II primer is 5Ј-CCIATGTAYYTIT-TYYTYWSGAATTCIWSITTI-3Ј, and the sequence for the TMD VII primer is 5Ј-AARTCIGGRSWICGISARTAIATSAIIGGRTT-3Ј. The PCR condition was 40 cycles of 94°C for 1 min, 45°C for 1.5 min, and 72°C for 2 min. After electrophoresis on agarose gels, three prominent bands of the expected size range (400 -1300 base pairs (bp)) were recovered from the gel and re-amplified by PCR under the same conditions. The final PCR products were cloned into pCR 2.1 using TOPO TA cloning kit (Invitrogen, Carlsbad, CA) and sequenced.
Cloning of Full-length Xenopus cDNAs-To obtain full-length cDNAs for the PCR products, we screened a Xenopus oocyte cDNA library (a gift from Dr. John Shuttleworth, University of Birmingham, UK) using a 32 P-labeled 560-bp PCR fragment as a probe. Two different full-length Xenopus LPA receptor isoforms were isolated as XLPAR-1 and XLPAR-10. XLPAR-1 contains 2053 bp, with 321 bp of 5Ј untranslated region and 631 bp of 3Ј untranslated region followed by a poly(A) tail. XLPAR-10 contains 1941 bp and lacks a poly(A) tail. These cDNA sequences were deposited in the EMBL data base with the accession numbers AJ249843 (XLPAR-1) and AJ249844 (XLPAR-10). In view of their high degree of homology to mammalian LP A1 , they are referred to here as XLP A1 -1 and XLP A1 -2 for XLPAR-1 and XLPAR-10, respectively. Nucleic acid and amino acid alignment was performed using the Clustal W multiple sequence alignment program found on the Web page of the DNA Data Bank of Japan.
Northern Blot Analysis-Tissues were quickly removed from female Xenopus, and total RNA was isolated from each tissue using Trizol according to the manufacturer's instructions (Life Technologies, Inc.). Northern blotting was performed as described previously (6, 13) , and membranes were analyzed with a Bio-Imaging analyzer BAS2500.
Electrophysiology in Xenopus Oocytes-Open reading frames (ORFs) of xlp A1 -1 and -2 were subcloned into BamHI-XhoI sites of the pBluescript SK(ϩ) vector (Stratagene). Constructs were linearized with KpnI digestion and used as a template in in vitro RNA transcription using mMESSAGE mMACHINE Kits (Ambion, Austin, TX). Xenopus oocyte preparation, cRNA injection, and electrophysiology were performed as described previously (22) . Briefly, stage V and VI oocytes from adult females were injected with 50 nl of appropriate cRNA (1 g/l) for overexpression and incubated at 16°C for 3-5 days in modified Barth saline (88 mM NaCl, 1 mM KCl, 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 2.4 mM NaHCO 3 , 10 mM Hepes (pH 7.4)) before recording. Oocytes were impaled by two microelectrodes filled with 3 M KCl and voltage-clamped at Ϫ50 mV. Only oocytes with resting potentials of less than Ϫ30 mV were used. Oocytes were continuously superfused with Ringer's solution (120 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 50 mM Hepes (pH 7.4), 0.1% (w/v) fatty acid-free bovine serum albumin) in the presence of LPA. For antisense oligonucleotide studies, injection of oocytes with 50 nl of oligonucleotides (2 g/l) was performed 3-5 days before recording. The antisense oligonucleotides were designed to complement 11-12 nucleotides 5Ј and 3Ј to the initiation codon for xlp A1 -1 or xlp A1 -2. All oligonucleotides were phosphorothioated near 5Ј and 3Ј ends (*) to prevent degradation (23) . Antisense oligonucleotide sequences were 5Ј-G*A*A*A*GAGAAGCCAUUUUAGC*C*C*A*G-3Ј for xlp A1 -1 and 5Ј-G*A*A*A*GCGAAGUCAUUUUAG*C*C*C*A*G-3Ј for xlp A1 -2. Because the antisense oligonucleotides differed by only two nucleic acids, a single sense-orientation oligonucleotide corresponding to the region targeted for xlp A1 -1 and -2 was used as a negative control (5Ј-C*U*G-*G*GCUAAAAUGGCUUCGC*U*U*U*C-3Ј). For the PTX experiments, Xenopus oocytes were incubated with 2 g/ml PTX in modified Barth saline for 48 h before recording.
Retrovirus Systems-The entire ORFs for xlp A1 -1 and -2 were subcloned into HindIII and XbaI sites of a pFLAG-CMV-1 mammalian expression vector (Eastman Kodak Co.) to introduce preprotrypsinleader/FLAG-tag sequences into amino-terminal extracellular regions of each receptor for immunocytochemical detection of the receptor proteins. These constructs were then subcloned into BamHI and XhoI sites of a Moloney murine leukemia retroviral vector, LZRS-EGFP (24) . Sequences of internal ribosomal entry sites in the vector enable concomitant expression of EGFP and FLAG-tagged receptors within the single cell (13) . The inserts of the constructs were confirmed by sequencing. Retrovirus supernatants were prepared using a Phoenix cell line, as described previously (13) .
Functional Assays-For the cell rounding assay, B103 cells were seeded onto glass coverslips coated with Cell-Tak (Becton Dickinson Labware, Bedford, MA) and infected with viral supernatants (13) . After treatment with LPA, cells were fixed with 4% (w/v) paraformaldehyde and incubated with the blocking solution (0.1% (w/v) Triton X-100, 0.25% (w/v) bovine serum albumin in phosphate-buffered saline). EGFP protein was visualized by incubation with anti-GFP polyclonal antibody, followed by incubation with fluorescein isothiocyanate-conjugated anti-rabbit IgG antibody (Vector Laboratories, Burlingame, CA). FLAG-tagged receptor was visualized by incubating cells with anti-FLAG antibody, followed by incubation with Cy3-conjugated antimouse IgG antibody (Jackson ImmunoResearch Laboratories, West Grove, PA). Cells were observed with a Zeiss Axiophot and a PlanNeofluor ϫ 40 objective (Carl Zeiss, Thornwood, NY) or a confocal laser-scanning microscope TCS NT and a PL APO 63 ϫ 1.20 waterimmersion objective (Leica, Deerfield, IL). For stress fiber formation assays, fixed RH7777 cells were immunostained for FLAG and polymerized actin, as previously described (5) . For measurement of intracellular cAMP contents, retrovirus-infected B103 cells were stimulated with LPA in the presence of 1 M forskolin and 0.5 mM 3-isobutyl-1-methylxanthine. Intracellular cAMP contents were measured using a cAMP enzyme-immunoassay system (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Statistical Analysis-Data shown are the means Ϯ S.E. from replicate samples from replicate experiments. Statistical analysis was performed by Student's t test.
RESULTS
Isolation of xlp A1 -1 and xlp A1 -2-To identify novel GPCRs in
Xenopus oocytes, we performed a PCR-based screen using degenerate oligonucleotide primers designed against TMD II and VII (6, 21) . The PCR amplifications resulted in three faint bands in the expected size range for the region between TMD II and TMD VII of GPCRs (400 -1300 bp) that were re-amplified and cloned. DNA sequencing identified two fragments with 90% identity in predicted amino acid sequences to those of the mammalian LP A1 receptor. These PCR fragments were then used as probes to screen a Xenopus oocyte cDNA library, and two different cDNAs (xlp A1 -1 and xlp A1 -2) were cloned, which encoded GPCRs consisting of 366 amino acids that differed by 6 amino acids (Fig. 1, A and B) . The comparison of nucleic acid sequences showed that xlp A1 -1 was 96% identical in the predicted ORF with xlp A1 -2, whereas there was much less identity in their 5Ј and 3Ј untranslated regions (69 and 61%, respectively; Fig. 1A ). Because the nucleotides that differ between xlp A1 -1 and -2 are distributed throughout the entire ORFs, xlp A1 -1 and -2 were probably encoded by different genes rather than produced by alternative splicing. Sequence alignment of these receptors with mouse and human LP A1 demonstrated high identity in both nucleic acid and predicted amino acid sequences. At the nucleic acid level, xlp A1 -1 was 75% identical to mouse lp A1 and 77% identical to human lp A1 , whereas xlp A1 -2 was 78% identical to mouse lp A1 and 77% identical to human lp A1 . A comparison of predicted amino acid sequences indicated that both clones were 89 -90% identical to both mouse and human LP A1 (Fig. 1B) . The amino acids were least conserved between Xenopus clones and mammalian LP A1 s in the first 24 amino acids of the amino-terminal regions (5 of 22 amino acids were identical).
Expression of xlp A1 -1 and -2 in Xenopus Tissues-To examine expression of xlp A1 -1 and -2 in Xenopus, total RNA from various tissues was isolated and analyzed by high stringency Northern blot analysis (Fig. 2) . The strongest signal was observed in oocytes, where a band of ϳ2.2 kb was observed. In addition, brain and spinal cord samples expressed this 2.2-kb band but also expressed larger species of ϳ5.8 and 11 kb (Fig. 2) . Because the nucleic acid sequences of xlp A1 -1 differed by only 3% from xlp A1 -2 and were dispersed throughout the ORFs, attempts to differentiate the forms by Northern blot analysis were unsuccessful. xlp A1 -1 and -2 expression was highest in oocytes, at lower levels in brain and spinal cord, and below detection in lung, heart, kidney, liver, muscle, stomach, and intestine. Heterologous Expression of XLP A1 -1 or -2 in Mammalian Cells-To examine additional signaling properties of XLP A1 -1 and -2 as compared with the known properties of mammalian LP A1 , each was expressed in B103 rat neuroblastoma cells (19) by infection with receptor-expressing recombinant retrovirus. The B103 cell line was chosen because it does not express any known LPA receptors and lacks endogenous responses to LPA, but does express appropriate ␣ subunits of heterotrimeric G proteins (G i/o , G q , and G 12/13 subtypes) that can couple with LPA receptors (5, 13) . Retroviral infection was used to introduce receptors into B103 cells to permit high efficiency expression and low cytotoxicity compared with conventional transfection methods (13) .
To ascertain whether XLP A1 -1 or -2 was expressed in infected B103 cells, immunohistochemistry was used to identify the epitope (FLAG)-tagged receptors. FLAG-tagged protein was detected as punctate labeling in both soma and neurites (Fig. 5, E, H, and K) . Consistent with retroviral mediated protein expression (see "Experimental Procedures" and Ref. 13) , EGFP protein was also strongly and ubiquitously expressed in all receptor-expressing cells (Fig. 5, A, D, G, and J) . Because the cells expressing EGFP proteins completely overlapped the cells expressing FLAG proteins (Fig. 5 and Ref. 13 ), EGFP fluorescence was used to monitor the infection efficiency before all functional assays. Typical infection percentages approximated 70 -90%.
Mouse LP A1 mediates LPA-induced cytoskeletal reorganization including cell rounding in B103 cells and stress fiber formation in RH7777 rat hepatoma cells (5, 6, 13) . To examine whether XLP A1 -1 and XLP A1 -2 also mediate cell rounding, B103 cells were infected, treated with various concentrations of LPA for 15 min, double-immunostained against EGFP and FLAG-tagged proteins, and observed by fluorescence micros- copy. Without treatment, B103 cells had neurites protruding from the cell body (Fig. 5, A, D, G, and J) , and after LPA stimulation, cells infected with control virus did not change their shapes (Figs. 5C and 6A) . In contrast, B103 cells expressing XLP A1 -1 or XLP A1 -2 and exposed to LPA resulted in an increase in rounded cells with retracted neurites (Figs. 5, F I, and 6A). The maximal effects and EC 50 values (ϳ10 nM) for LPA were comparable with those observed for cells expressing mouse LP A1 (Figs. 5L and 6A) . LPA-induced cell rounding in cells expressing XLP A1 -1 or XLP A1 -2 was completely inhibited by pretreatment with a Rho kinase inhibitor, Y-27632 (29), but not with PTX pretreatment (data not shown).
As with B103 cells, RH 7777 cells neither express any known LPA receptors nor show endogenous response to LPA (5). However, heterologous expression of mouse LP A1 in these cells produces LPA-dependent stress fiber formation (5) . Heterologous expression of XLP A1 -1 or XLP A1 -2 increased the percentage of cells with stress fibers following LPA stimulation (1.9% in control cells, 29.1% in XLP A1 -1-expressing cells, and 32.0% in XLP A1 -2-expressing cells). This effect was comparable in extent and completely indistinguishable from the stress fibers produced in previous studies of mouse LP A1 -expressing cells (5) .
Mouse LP A1 mediates LPA-induced inhibition of adenylyl cyclase in B103 cells (13) , TR immortalized neuroblast cells (6) , and HTC4 hepatoma cells (11) . Infected B103 cells were incubated with forskolin (1 M) in the absence or presence of various concentrations of LPA for 15 min. Intracellular cAMP content was measured by enzyme immunoassay. Forskolininduced cAMP accumulation in B103 cells expressing XLP A1 -1 or XLP A1 -2 was inhibited by LPA treatment (Fig. 6B) . Maximal inhibition in both was ϳ32% and was smaller than that observed in cells expressing mouse LP A1 (ϳ63%). However, the EC 50 values for inhibition were comparable among XLP A1 -1, XLP A1 -2, and mouse LP A1 (ϳ10 nM). This inhibition was completely blocked by PTX pretreatment (data not shown).
DISCUSSION
In this study, we identified and characterized two novel Xenopus GPCRs, XLP A1 -1 and XLP A1 -2. Based on nucleotide and amino acid sequence similarities, endogenous expression in Xenopus tissues, and their function in both oocytes and mammalian cells, XLP A1 -1 and XLP A1 -2 are functional Xenopus homologs of the mammalian high affinity LPA receptor LP A1 .
A comparison of nucleic acid sequences, including divergent untranslated regions, and predicted amino acid sequences of xlp A1 -1 and xlp A1 -2 indicates that they are derived from two distinct genes rather than generated by alternative splicing of a single gene. The existence of multiple genes for a given function is not uncommon for Xenopus laevis (20, 30 -33) , in part reflecting the occurrence of genome duplication in Xenopus that results in a tetraploid (allotetraploid) genome (34) .
xlp A1 -1 and/or -2 mRNA was expressed at high levels in oocytes and at lower levels in brain and spinal cord among the various Xenopus tissues examined. Alignment of amino acid sequences revealed that both XLP A1 -1 and XLP A1 -2 were highly similar to mammalian LP A1 (ϳ89% identity) (3, 4, 35) . By contrast, no signal was detected after Northern blot hybridization with mouse LP A2 or LP A3 probes under conditions allowing detection of XLP A1 -1 and XLP A1 -2 using mouse LP A1 (data not shown). This result suggests that Xenopus homologs of mammalian LP A2 or LP A3 do not exist in the Xenopus tissues examined or, at least, not those with the same degree of similarity as between mouse and Xenopus LP A1 .
In Xenopus oocytes, endogenous LPA-evoked Cl Ϫ currents have been reported to be mediated through the activation of G q and phospholipase C, based on studies using pharmacological or antisense oligonucleotide approaches (28, 36) . In studies of mammalian LP A1 , it was recently reported that LPA stimulates phospholipase C through G q pathways (13) . Combined with data from the present study including PTX-insensitive augmentation of LPA-evoked Cl Ϫ currents by xlp A1 , we conclude that endogenous LPA responses probably are mediated by G q activation via XLP A1 s.
In addition to G q activation, both XLP A1 s stimulate Rho (perhaps through G 12/13 ) and G i pathways, resulting in cell rounding and stress fiber formation, and inhibition of cAMP accumulation, respectively. All responses are similar to those observed directly in previous studies of mammalian LP A1 (5, 13) . The EC 50 of LPA for cytoskeletal changes, as well as adenylyl cyclase inhibition in cells expressing XLP A1 , is below 10 nM, which is comparable with that of mouse LP A1 (5, 13) . These results strongly support the identification of XLP A1 -1 and -2 as LPA receptors in Xenopus.
Xenopus oocytes appear to express both high and low affinity receptors for LPA based on electrophysiological studies of LPAdependent Cl Ϫ currents (25, 37, 38) . Guo et al. (15) have reported a high affinity site for LPA with an EC 50 of 12 nM and a low affinity site of 1 M. Here, we observed that overexpression of XLP A1 -1 or -2 potentiated the Cl Ϫ currents evoked by application of low concentrations (3-10 nM) of LPA. Injection of antisense oligonucleotide designed to inhibit expression of endogenous XLP A1 -1 and -2 completely inhibited the Cl Ϫ currents evoked by the application of 10 nM LPA. Combined with the data from heterologous expression, we conclude that XLP A1 -1 and XLP A1 -2 are high affinity LPA receptors in Xenopus oocytes.
It should be noted that a different gene, PSP24, was previously reported to encode Xenopus high affinity LPA receptor, based on the potentiation of LPA-evoked Cl Ϫ currents in oocytes following its overexpression (15) . Xenopus PSP24 is dissimilar to mammalian LPA receptors, having less than 20% amino acid sequence identity with mammalian LP A1 (4). Moreover, heterologous expression of Xenopus PSP24 in yeast and of mammalian orthologs of PSP24 in mammalian cells does not mediate LPA responses (7, 16) . Our data did not directly address the role of PSP24, because experimental results focused on XLP A1 -1 and XLP A1 -2 were sufficient to account for measured LPA responses in Xenopus oocytes. It is possible that an indirect relationship exists between XLP A1 -1 and XLP A1 -2 and PSP24, although we note the existence of technical difficulties in examining altered gene expression or post-translational changes in single, injected, and electrophysiologically characterized oocytes. The precise mechanism for LPA-evoked effects related to PSP24 in oocytes remains for future work, along with the question of what receptor mechanisms mediate the low affinity LPA interactions, which were not addressed in this study.
In summary, we have identified and characterized two high affinity Xenopus LPA receptors, both of which are similar in structure and function to mammalian LP A1 receptors. The existence of XLP A1 s provides a more evolutionarily frugal mechanism for LPA signaling that appears to be conserved from Xenopus through humans.
